Sarepta Therapeutics(SRPT) - 2025 Q4 - Annual Report
2026-03-02 12:02
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number : 001-14895 Sarepta Therapeutics, Inc. (Exact name of registrant as specified in its charter) Delaware 93-0797222 (State or other jurisdi ...
RadNet(RDNT) - 2025 Q4 - Annual Results
2026-03-02 12:01
Dr. Howard Berger, President and Chief Executive Officer of RadNet, commented, "I am very pleased with the fourth quarter performance. Relative to last year's fourth quarter, Total Company Revenue increased 14.8% and Adjusted EBITDA increased 16.9%, resulting in margin improvement of 29 basis points. This performance was driven by strong aggregate and same center procedural growth, combined with a continued focus on driving operating and clinical efficiencies within the Imaging Center segment. These factors ...
AAON(AAON) - 2025 Q4 - Annual Results
2026-03-02 12:01
AAON Reports Fourth Quarter and Full Year 2025 Results Carries Record Backlog into 2026 Full Year 2025 Results (All comparisons are year-over-year, unless otherwise noted) Fourth Quarter 2025 Results (All comparisons are year-over-year, unless otherwise noted) Company Introduces 2026 Outlook • 2026 outlook reflects revenue growth of 18-20% and gross margins of approximately 29-31%, supported by record backlog, expanded capacity, and improving operational execution Exhibit 99.1 TULSA, Okla., March 2, 2026 - ...
ADT(ADT) - 2025 Q4 - Annual Results
2026-03-02 12:01
Financial Performance - Total revenue for 2025 was $5.129 billion, an increase of 5% year-over-year[4] - Adjusted EPS for 2025 was $0.89, up 19% from the previous year[4] - Total revenue for Q4 2025 was $1,276 million, a 1% increase from $1,260 million in Q4 2024[30] - For the full year 2025, total revenue reached $5,129 million, up 5% from $4,898 million in 2024[30] - Operating income for Q4 2025 was $333 million, representing a 9% increase compared to $305 million in Q4 2024[30] - Net income for Q4 2025 was $145 million, a decrease of 23% from $190 million in Q4 2024[30] - The diluted earnings per share for Q4 2025 was $0.17, down from $0.21 in Q4 2024[30] - Net income for the twelve months ended December 31, 2025, increased to $596 million, up 19% from $501 million in 2024[36] - Adjusted income from continuing operations for the twelve months ended December 31, 2025, was $750 million, compared to $685 million in 2024, representing a 9.5% increase[62] Cash Flow and Expenses - Adjusted Free Cash Flow for 2025 was $863 million, an increase of 16% year-over-year[13] - Free Cash Flow for the twelve months ended December 31, 2025, was $716 million, an increase of 17% compared to $612 million in 2024[48] - Adjusted Free Cash Flow for the twelve months ended December 31, 2025, rose to $798 million, up 21% from $659 million in 2024[48] - Selling, general, and administrative expenses decreased by 5% to $360 million in Q4 2025 compared to $380 million in Q4 2024[30] - Interest expense increased by 34% to $110 million in Q4 2025, compared to $82 million in Q4 2024[30] - Interest expense for the twelve months ended December 31, 2025, was $459 million, compared to $441 million in 2024, reflecting a rise of 4.1%[54] Shareholder Returns - The company returned $791 million to shareholders in 2025, including $604 million in share repurchases[14] - The company announced a new $1.5 billion share repurchase authorization effective March 2, 2026[17] Assets and Liabilities - Total assets decreased from $16,051 million in December 2024 to $15,819 million in December 2025, a decline of 1.4%[33] - Long-term debt decreased slightly from $7,511 million in December 2024 to $7,379 million in December 2025, a reduction of 1.8%[33] - Current liabilities decreased from $1,264 million in December 2024 to $1,013 million in December 2025, a decline of 20%[33] - Total stockholders' equity remained relatively stable, decreasing slightly from $3,801 million in December 2024 to $3,779 million in December 2025[33] Operational Highlights - Recurring monthly revenue (RMR) at the end of 2025 was $359 million, with a gross revenue attrition rate of 13.1%[4] - The company launched new safety features and expanded its ADT+ platform, integrating with Google Nest and Yale devices[8] - The company is focusing on integrating AI into its products and services, including customer interactions and operational efficiencies[29] - ADT was added to the S&P SmallCap 600 index effective February 9, 2026, highlighting its strong performance[8] Financial Ratios - The company achieved a net leverage ratio target of 2.5x or below as part of its multi-year financial framework[15] - The net leverage ratio improved to 2.7x as of December 31, 2025, down from 2.9x in the prior year, indicating better credit position[68] Other Financial Metrics - Adjusted EBITDA from continuing operations for Q4 2025 was $670 million, compared to $653 million in Q4 2024, reflecting a year-over-year increase of 2.6%[54] - Adjusted EBITDA margin for Q4 2025 was 53%, slightly up from 52% in Q4 2024, indicating stable operational profitability[54] - The company reported a goodwill impairment charge of $12 million associated with the Multifamily Divestiture during the year[55]
Park Ha Biological Technology Co., Ltd.(PHH) - 2025 Q4 - Annual Report
2026-03-02 11:57
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(B) OR 12(G) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended October 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1 ...
Biglari (BH_A) - 2025 Q4 - Annual Results
2026-03-02 11:35
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 28, 2026 BIGLARI HOLDINGS INC. (Exact Name of Registrant as Specified in Charter) Indiana 001-38477 82-3784946 (Former Name or Former Address, if Changed Since Last Report.) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligati ...
Biglari (BH) - 2025 Q4 - Annual Results
2026-03-02 11:35
Earnings Announcement - Biglari Holdings Inc. announced its earnings for the fourth quarter and year ended December 31, 2025, on February 28, 2026[4]. - The press release detailing the earnings is included as an exhibit to the Form 8-K filing[4]. Annual Report - The 2025 Annual Report to shareholders is available online, including Sardar Biglari's annual letter[6].
Biglari (BH) - 2025 Q4 - Annual Report
2026-03-02 11:32
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____ to ____ Commission file number 001-38477 BIGLARI HOLDINGS INC. (Exact name of registrant as specified in its charter) 19100 Ridgewood Parkway, Suite 1200 San Antonio, Te ...
Biglari (BH_A) - 2025 Q4 - Annual Report
2026-03-02 11:32
Financial Performance - Net earnings attributable to Biglari Holdings Inc. shareholders for 2025 were $(37,488) thousand, a decrease from $(3,759) thousand in 2024, compared to $54,948 thousand in 2023[101]. - Total revenue for the restaurant segment in 2025 was $280,870 thousand, an increase of $29,423 thousand or 11.7% compared to $251,447 thousand in 2024[108]. - Net sales for company-operated units in 2025 were $181,884 thousand, representing an increase of $22,671 thousand or 14.2% compared to 2024, driven by a 10.5% increase in same-store sales[109]. - Franchise partner fees increased to $77,001 thousand in 2025 from $70,616 thousand in 2024, with a same-store sales increase of 10.1%[111]. - The underwriting gain for the insurance segment in 2025 was $7,210 thousand, compared to $4,438 thousand in 2024, with a net underwriting gain of $5,696 thousand[123]. Costs and Expenses - The cost of food at company-operated units was $56,205 thousand, or 30.9% of net sales in 2025, up from $47,891 thousand or 30.1% in 2024, primarily due to inflation[114]. - Labor costs at company-operated restaurants were $56,175 thousand, or 30.9% of net sales in 2025, compared to $50,431 thousand, or 31.7% in 2024[115]. - General and administrative expenses were $48,969 thousand, or 17.4% of total revenue in 2025, an increase from $47,130 thousand, or 18.7% in 2024[116]. - Marketing expenses increased to $17,951 thousand, or 6.4% of total revenue in 2025, from $12,584 thousand, or 5.0% in 2024, primarily due to new product promotions[117]. Insurance Segment Performance - Premiums written increased to $71,041 million in 2025, up from $68,394 million in 2024, representing a growth of 3.8%[124]. - First Guard's underwriting gain in 2025 was $6,015 million, a 49.0% increase compared to $4,038 million in 2024[127]. - Southern Pioneer reported a 19.0% increase in premiums earned to $33,473 million in 2025, up from $28,118 million in 2024[129]. Oil and Gas Revenue - Oil and gas revenue decreased to $30,211 million in 2025, down 18.3% from $36,945 million in 2024[133]. - Abraxas Petroleum's revenue declined by $5,592 million, or 24.8%, to $16,998 million in 2025 due to lower crude oil prices[135]. - Southern Oil's revenue decreased by $1,142 million, or 8.0%, to $13,213 million in 2025, attributed to lower sales prices of crude oil[138]. Licensing and Media Revenue - Maxim's licensing and media revenue surged to $7,717 million in 2025, a significant increase from $1,029 million in 2024[140]. Investment and Financing Activities - Investment partnership losses were $67,001 million in 2025, compared to losses of $41,058 million in 2024[143]. - The consolidated income tax benefit increased to $10,203 million in 2025 from $4,395 million in 2024, driven by taxes on income from investment partnerships[148]. - Interest expense on notes payable rose to $8,221 million in 2025, significantly higher than $771 million in 2024, due to new borrowings[147]. - Consolidated shareholders' equity decreased to $523,429 as of December 31, 2025, down $49,532 from the previous year, primarily due to a net loss of $37,488[150]. - Total cash and investments increased to $1,110,417 in 2025, up from $789,950 in 2024, with cash and cash equivalents rising significantly to $268,782[152]. - Net cash provided by operating activities rose to $106,959 in 2025, an increase of $57,299 compared to 2024, largely due to $56,000 in distributions from investment partnerships[154]. - Cash used in investing activities decreased by $21,918 in 2025, primarily due to a $33,411 increase in sales of investments and redemptions of fixed maturity securities[155]. - Financing activities provided $196,533 in 2025, a significant increase of $157,049 compared to 2024, driven by a $225,000 note payable from Steak n Shake[155]. - The line of credit balance was $27,250 as of December 31, 2025, down from $35,000 in 2024, with an interest rate of 6.7%[157]. - Steak n Shake obtained a loan of $225,000 on September 30, 2025, with a fixed interest rate of 8.8% and a five-year term[159]. - The carrying value of cash and investments on the balance sheet was $492,107 as of December 31, 2025, compared to $335,411 in 2024[152]. Corporate Performance - Corporate expenses for 2025 were reported at a net loss of $16,000, an increase from $12,503 in 2024, mainly due to higher professional fees[149]. - The company maintains significant liquidity, with cash flow activities reflecting a strong operational performance[153]. - The company operated 435 restaurants as of December 31, 2025, a decrease from 492 in 2024, with plans to reopen two closed locations and sell or lease five[105].
Zymeworks(ZYME) - 2025 Q4 - Annual Report
2026-03-02 11:28
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________ ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________to ___________ Commission file number: 001-41535 _________________________ FORM 10-K _________________________ (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 or ZYMEWOR ...